Uncategorized

Noxopharm to Speak at ACCESS CHINA Partnering Forum

December 20th, 2024 (Shanghai) — We are glad to announce that Dr. Xiang Li, Senior Research Scientist of Noxopharm, will be presenting at the ACCESS CHINA Partnering Forum @ JPM on January 7th-9th, and 21st-23rd, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the Western biopharma industry.

Noxopharm Limited (ASX:NOX) is an innovative Australian biotech company discovering and developing novel treatments for inflammation, including a pioneering technology to enhance mRNA vaccines.

The company utilises specialist in-house capabilities and strategic partnerships with leading researchers to build a growing pipeline of new proprietary drugs based on its Sofra™ technology platform for inflammation, autoimmunity, and mRNA vaccine enhancement.

To learn more, please visit: noxopharm.com

Dr. Xiang Li is a Senior Research Scientist at Noxopharm Limited, where he also drives BD activities in China. He is an experienced biomedical researcher with over 14 years of experience managing and conducting diversified, cutting-edge projects in stem cell therapy, CRISPR gene editing, inflammatory diseases and cancer at The University of Hong Kong, Imperial College London and Duke University.

ACCESS CHINA Partnering Forum @ JPM is scheduled to be held on January 7th-9th, and 21st-23rd, 2025, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, the audience can have access to innovative pharma and healthcare products from worldwide.

Conference Name: ACCESS CHINA Partnering Forum

Date & Time: January 7-9 (Live), and 21-23(VoD), 2025, China time

Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception

Scale: Expected 500+ participants Online; 100 company roadshows

Participants: Pharma/Biotech senior management and BDs

View more information at https://biotochina.org/

To register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum

For more information, please contact:

Wendi Xiang

Wxiang@yafocapital.com